Pathogenesis of NSAID-induced gastroduodenal mucosal injury

Best Practice and Research: Clinical Gastroenterology

Volumn 15, Issue 5, 2001, Pages 691-703

  Wallace, John L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Acid; Cyclooxygenase; Neutrophils; Nitric oxide; Non steroidal anti inflammatory drug; Ulcer

Indexed keywords

ACETYLSALICYLIC ACID; CD11 ANTIGEN; CD18 ANTIGEN; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; GROWTH FACTOR; LEUKOTRIENE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM INJURY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; GASTRODUODENAL ULCER; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL MUCOSA; HEMOSTASIS; HUMAN; INTESTINE EPITHELIUM; INTESTINE INJURY; MICROCIRCULATION; MOUSE; NONHUMAN; PATHOGENESIS; PROSTAGLANDIN SYNTHESIS INHIBITION; RAT; STOMACH ACID; ULCER HEALING;

EID: 0034758114     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2001.0229     Document Type: Article

References (96)

1. Gastroscopic observation of the effect of aspirin and certain other substances on the stomach
2. NSAID induced ulcers. An emerging epidemic?
3. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study
4. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
5. 2
6. A review of gastric ulcer and gastroduodenal injury in normal volunteers receiving aspirin and other nonsteroidal anti-inflammatory drugs
7. Relationship of gastric mucosal damage induced in pigs by antiinflammatory drugs to their effects on prostaglandin production
8. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat
9. Tissue-selective inhibition of prostaglandin synthesis in rat by tepoxalin: Anti-inflammatory without gastropathy
10. NSAID-induced gastric damage in the rat: Requirement for inhibition of both cyclooxygenase-1 and -2
11. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years
12. The cellular and molecular basis for gastroduodenal mucosal defense
13. Cooperative modulation of gastrointestinal mucosal defence by prostaglandins and nitric oxide
14. Nitric oxide and mucosal defence: A little goes a long way
15. Impaired vasodilatory responses in the gastric microcirculation of cirrhotic rats
16. Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts
17. Aspirin induces a rapid up-regulation of cyclooxygenase-2 expression in the rat stomach
18. Induction of cyclooxygenase-1 and -2 in the rat stomach during endotoxemia: Role in resistance to damage
19. Selective cyclo-oxygenase-2 inhibitors aggravate ischaemia-reperfusion injury in the rat stomach
20. Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach
21. Induction of cyclooxygenase-2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice
22. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats
23. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2
24. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
25. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
26. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis
27. The mucoid cap over superficial gastric damage in the rat. A high-pH microenvironment dissipated by nonsteroidal antiinflammatory drugs and endothelin
28. Sensory neurons signal for an increase in rat gastric mucosal blood flow in the face of pending acid injury
29. Focal gastric mucosal blood flow at the site of aspirin-induced ulceration
30. Effect of aspirin plus hydrochloric acid on the gastric mucosal microcirculation
31. Focal gastric mucosal blood flow in aspirin-induced ulceration
32. Microvascular injury during gastric damage by anti-inflammatory drugs in pigs and rats
33. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process
34. Leukocyte-endothelial cell adhesion caused by ischemia and reperfusion
35. Granulocytes: The culprit in ischemic damage to the intestine
36. Indomethacin-induced leukocyte adhesion in mesenteric venules: Role of lipoxygenase products
37. Modulation of leukocyte adhesion to rat mesenteric venules by aspirin and salicylate
38. Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury
39. Effect of nonsteroidal anti-inflammatory drugs on LFA-1 and ICAM-1 expression in gastric mucosa
40. A monoclonal antibody against the CD18 leukocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit
41. Oxygen free radicals interact with indomethacin to cause gastrointestinal injury
42. Role of oxygen-derived free radicals in indomethacin-induced gastric injury
43. Aspirin-induced, neutrophil-mediated injury to vascular endothelium
44. Plaunotol prevents indomethacin-induced gastric mucosal injury in rats by inhibiting neutrophil activation
45. Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: Role of tumour necrosis factor alpha
46. Prostaglandins inhibit inflammatory mediator release from rat mast cells
47. Regulation of macrophage tumor necrosis factor production by prostaglandin E2
48. Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies
49. Tumour necrosis factor mediation of NSAID-induced gastric damage: Role of leukocyte adherence
50. The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by nonsteroidal antiinflammatory drugs in mice
51. Vascular injury in acute gastric mucosal damage: Mediatory role of leukotrienes
52. A pharmacological investigation of the role of leukotrienes in the pathogenesis of experimental NSAID-gastropathy
53. 4 synthesis in patients taking non-steroidal anti-inflammatory drugs
54. Molecular determinants of aspirin-induced neutrophil adherence to endothelial cells
55. Characterization of a simple animal model for nonsteroidal anti-inflammatory drug induced antral ulcer
56. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs
57. Gastric ulcer perforation, associated with the use of injectable ketorolac
58. Gastric mucosal hemorrhage in dogs. Effects of acid, aspirin, and alcohol
59. How do non-steroidal anti-inflammatory drugs affect gastric mucosal defenses?
60. The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: A review and a hypothesis
61. Mitochondrial function and modification of NSAID carboxyl moiety
62. The hydrophobic barrier properties of gastrointestinal mucus
63. Does aspirin damage canine gastric mucosa by reducing its hydrophobicity?
64. Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: Insight into the mechanism and reversal of NSAID-induced gastrointestinal injury
65. Effect of naproxen on gastric mucosal hydrophobicity
66. Nonsteroidal anti-inflammatory effect of sulindac sulfoxide and sulfide on gastric mucosa
67. The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs
68. Aspirin-induced gastric mucosal damage: Prevention by enteric-coating and relation to prostaglandin synthesis
69. The roles of ethanol and of acid in the production of gastric mucosal erosions in rats
70. Restitution of the surface epithelium of the in vitro frog gastric mucosa after damage with hyperosmolar sodium chloride
71. Rapid epithelial restitution of the rat gastric mucosa after ethanol injury
72. Rapid barrier restitution in an in vitro model of intestinal epithelial injury
73. Role of mucus in repair of gastric epithelial damage in the rat. Inhibition of epithelial recovery by mucolytic agents
74. Effects of acid on the basal lamina of the rat stomach and duodenum
75. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration
76. Diclofenac delays healing of gastroduodenal mucosal lesions. Double-blind, placebo-controlled endoscopic study in healthy volunteers
77. Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa
78. Selective COX-2 inhibitors: Is the water becoming muddy?
79. Selective inhibitors of COX-2: Are they really effective? Are they really GI-safe?
80. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
81. Misoprostol healed a benign nonsteroidal anti-inflammatory drug-induced gastric ulcer in a patient with pentagastrin-fast achlorhydria
82. Achlorhydria does not protect against benign upper gastrointestinal ulcers during NSAID use
83. Epidemiology and prevention of non-steroidal anti-inflammatory drug effects in the gastrointestinal tract
84. Prevention of NSAID-induced gastroduodenal mucosal injury: Meta-analysis of clinical trials with misoprostol and H2-receptor antagonists
85. A dose-ranging study of famotidine in prevention of gastroduodenal lesions associated with non-steroidal anti-inflammatory drugs (NSAIDs): Results of a U.S. multicenter trial
86. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs
87. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs
88. Effect of acid and pepsin on blood coagulation and platelet aggregation: A possible contributor to prolonged gastroduodenal mucosal hemorrhage
89. Accelerated healing of duodenal ulcers by oral administration of a basic fibroblast growth factor in rats
90. Mechanisms of action of antisecretory drugs: Studies on isolated canine fundic mucosal cells
91. Prostaglandins mediate inhibition of gastric acid secretion by somatostatin in the rat
92. Role of cyclooxygenase-2 in modulating gastric acid secretion in the normal and inflamed rat stomach
93. What consideration should be given to Helicobacter pylori in treating nonsteroidal anti-inflammatory drug ulcers?
94. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers
95. Novel NSAID derivatives with markedly reduced ulcerogenic properties
96. Gastrointestinal sparing anti-inflammatory drugs: The development of nitric oxide-releasing NSAIDs